|
 |
|
|||||||
|
|||||||||
© 2003 by the American Diabetes Association, Inc.
Clinical Care/Education/Nutrition |
The Efficacy and Safety of Dermagraft in Improving the Healing of Chronic Diabetic Foot Ulcers
Results of a prospective randomized trial
1 University of North Carolina School of Medicine, Chapel Hill, North Carolina
2 Foot & Ankle Institute of South Florida, South Miami, Florida
3 Valley Endocrine, Fresno, California
4 University of Texas Health Science Center, San Antonio, Texas; and the Dermagraft Joint Venture, La Jolla, California
OBJECTIVE—To determine if a human fibroblast–derived dermal substitute could promote the healing of diabetic foot ulcers.
RESEARCH DESIGN AND METHODS—A randomized, controlled, multicenter study was undertaken at 35 centers throughout the U.S. and enrolled 314 patients to evaluate complete wound closure by 12 weeks. Patients were randomized to either the Dermagraft treatment group or control (conventional therapy). Except for the application of Dermagraft, treatment of study ulcers was identical for patients in both groups. All patients received pressure-reducing footwear and were allowed to be ambulatory during the study.
RESULTS—The results demonstrated that patients with chronic diabetic foot ulcers of >6 weeks duration experienced a significant clinical benefit when treated with Dermagraft versus patients treated with conventional therapy alone. With regard to complete wound closure by week 12, 30.0% (39 of 130) of Dermagraft patients healed compared with 18.3% (21 of 115) of control patients (P = 0.023). The overall incidence of adverse events was similar for both the Dermagraft and control groups, but the Dermagraft group experienced significantly fewer ulcer-related adverse events.
CONCLUSIONS—The data from this study show that Dermagraft is a safe and effective treatment for chronic diabetic foot ulcers.
CiteULike 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  E. Blozik and M. Scherer Skin Replacement Therapies for Diabetic Foot Ulcers: Systematic review and meta-analysis Diabetes Care, April 1, 2008; 31(4): 693 - 694. [Full Text] [PDF]
|
|
|
|
|
|
P. A. Blume, J. Walters, W. Payne, J. Ayala, and J. Lantis Comparison of Negative Pressure Wound Therapy Using Vacuum-Assisted Closure With Advanced Moist Wound Therapy in the Treatment of Diabetic Foot Ulcers: A multicenter randomized controlled trial Diabetes Care, April 1, 2008; 31(4): 631 - 636. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. T. Bloomgarden The Diabetic Foot Diabetes Care, February 1, 2008; 31(2): 372 - 376. [Full Text] [PDF]
|
|
|
|
|
|
P. Ince, F. L. Game, and W. J. Jeffcoate Rate of Healing of Neuropathic Ulcers of the Foot in Diabetes and Its Relationship to Ulcer Duration and Ulcer Area Diabetes Care, March 1, 2007; 30(3): 660 - 663. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Miller, T. A. DeCoster, and M. S. Mizel What's New in Foot and Ankle Surgery? J. Bone Joint Surg. Am., April 1, 2005; 87(4): 909 - 917. [Full Text] [PDF]
|
|
|
|
 |
|
 A. J.M. Boulton, R. S. Kirsner, and L. Vileikyte Neuropathic Diabetic Foot Ulcers N. Engl. J. Med., July 1, 2004; 351(1): 48 - 55. [Full Text] [PDF]
|
|
|
|
 |
|
 C. L. Smith Pharmacotherapy of Diabetic Foot Ulcers Journal of Pharmacy Practice, February 1, 2004; 17(1): 66 - 74. [Abstract] [PDF]
|
|
|
|
 |
|
 Other articles noted: 25 Jul 03 to 7 Nov 03 Evid. Based Nurs., January 1, 2004; 7(1): e1 - 1. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Diabetes | Diabetes Care | Clinical Diabetes | Diabetes Spectrum |